YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.88
-0.08 (-0.50%)
Jul 29, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
Anti-viral Drugs
2.80B
Log In
Log In
Log In
Log In
Upgrade
Anti-viral Drugs Growth
-54.56%
Log In
Log In
Log In
Log In
Upgrade
Other Medical Products and License Fee
547.83M
Log In
Log In
Log In
Log In
Upgrade
Other Medical Products and License Fee Growth
91.49%
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular Drugs
293.01M
Log In
Log In
Log In
Log In
Upgrade
Cardiovascular Drugs Growth
44.02%
Log In
Log In
Log In
Log In
Upgrade
Endocrine and Metabolic Drugs
269.98M
Log In
Log In
Log In
Log In
Upgrade
Endocrine and Metabolic Drugs Growth
48.82%
Log In
Log In
Log In
Log In
Upgrade
Anti-infectives Drugs
124.33M
Log In
Log In
Log In
Log In
Upgrade
Anti-infectives Drugs Growth
5.24%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 NaN - NaN
China
4.04B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-41.95%
Log In
Log In
Log In
Log In
Upgrade